A case of giant ameloblastoma: destructive effect on the facial skeleton and soft tissues of the head and neck
Language English Country Great Britain, England Media print
Document type Case Reports, Journal Article
PubMed
34648377
PubMed Central
PMC8521770
DOI
10.1177/03000605211050185
Knihovny.cz E-resources
- Keywords
- Ameloblastoma, computed tomography, facial skeleton, hemimandibulectomy, mandible, tissue destruction,
- MeSH
- Ameloblastoma * diagnostic imaging surgery MeSH
- Head MeSH
- Neck MeSH
- Humans MeSH
- Mandible MeSH
- Tomography, X-Ray Computed MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
Ameloblastoma is a benign odontogenic tumor characterized by slow growth causing painless facial swelling. The tumor can behave locally aggressively, and may have direct destructive effects on the surrounding soft and hard tissues. This paper reports the unique case of a female patient with giant ameloblastoma of the mandible. Computed tomography (CT) revealed an enormous swelling of the left side of the face, resorption of the affected hemi-mandible, left maxilla, and tissues of the temporal, infratemporal, and pterygopalatine fossae. Pressure from the tumor resulted in displacement and destruction of the facial skeleton, upper aero-digestive tract structures, and some structures of the neck. The patient was treated by radical hemimandibulectomy with removal of the tumorous mass. Precise knowledge of the anatomical structures, and their locations and topographical relationships is required in the diagnosis and treatment plan for each surgical procedure in cases of giant ameloblastoma. CT imaging can be used to determine the extent and exact location of the lesion, revealing other important details that may help in selecting appropriate treatment.
See more in PubMed
Effiom OA, Ogundana OM, Akinshipo AO, et al.. Ameloblastoma: current etiopathological concepts and management. Oral Dis 2018; 24: 307–316. PubMed
Rajaonarison Ny Ony N, Randriamarolahy A, Randrianjanahary OME, et al.. Giant ameloblastoma. Clin Imaging 2012; 36: 146–148. PubMed
Hendra FN, Van Cann EM, Helder MN, et al.. Global incidence and profile of ameloblastoma: a systematic review and meta-analysis. Oral Dis 2020; 26: 12–21. PubMed
Kreppel M andZöller J.. Ameloblastoma – clinical, radiological, and therapeutic findings. Oral Dis 2018; 24: 63–66. PubMed
Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer B Oral Oncol 1995; 31B: 86–99. PubMed
Dhanuthai K, Chantarangsu S, Rojanawatsirivej S, et al.. Ameloblastoma: a multicentric study. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 113: 782–788. PubMed
Kitisubkanchana J, Reduwan NH, Poomsawat S, et al.. Odontogenic keratocyst and ameloblastoma: radiographic evaluation. Oral Radiol 2021; 37: 55–65. PubMed
Soylu E, Bayındır S, Demirbaş AE, et al. . How often are ameloblastomas in middle anatolia? a 13-year retrospective study. Ann Clin Anal Med 2020; doi:10.4328/ACAM.20275. Available at: http://www.bayrakol.org/en/about-acam/publish-online/item/2443-how-often-are-ameloblastomas-in-middle-anatolia-a-13-year-retrospective-study
Alves DBM, Tuji FM, Alves FA, et al.. Evaluation of mandibular odontogenic keratocyst and ameloblastoma by panoramic radiograph and computed tomography. Dentomaxillofac Radiol 2018; 47: 20170288. PubMed PMC
Almeida RAC, Andrade ES, Barbalho JC, et al.. Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis. Int J Oral Maxillofac Surg 2016; 45: 359–367. PubMed
Meng Y, Zhao YN, Zhang YQ, et al.. Three-dimensional radiographic features of ameloblastoma and cystic lesions in the maxilla. Dentomaxillofac Radiol 2019; 48: 20190066. PubMed PMC
Sarlabous M andPsutka D.. Treatment of mandibular ameloblastoma involving the mandibular condyle: resection and concomitant reconstruction with a custom hybrid total joint prosthesis and iliac bone graft. J Craniofac Surg 2018; 29: e307–e314. PubMed
Gagnier JJ, Kienle G, Altman DG, et al.. CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. Headache 2013; 53: 1541–1547. PubMed